Permeon Biologics

About:

Permeon Biologics is a developer of therapeutic drugs for the enhancement of human health.

Top Investors: Flagship Pioneering, ARCH Venture Partners

Description:

Permeon Biologics aims to enhance human health by using their novel Intraphilin Technology Platform™ to enable intracellular biologics as a revolutionary new generation of therapeutic drugs.

Total Funding Amount:

$2.5M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2008-01-01

Contact Email:

info(AT)permeonbio.com

Founders:

David Liu

Number of Employees:

11-50

Last Funding Date:

2011-12-30

IPO Status:

Private

Industries: